<DOC>
	<DOCNO>NCT02705040</DOCNO>
	<brief_summary>This study aim evaluate role specific miRNAs osteoporosis men .</brief_summary>
	<brief_title>Roles microRNAs Development Osteoporosis Men - Preliminary Study</brief_title>
	<detailed_description>In past , osteoporosis usually view woman disease . However , men woman show lose bone mass rate 65 age , osteoporosis men cause high mortality men woman . Thus , osteoporosis men recently arouse public attention . Androgen deficiency main cause lead osteoporosis . Bone structure maintain dynamic balance osteoblast-mediated bone formation osteoclast-mediated bone resorption . Androgens androgen receptor ( AR ) play critical role regulation bone formation resorption . MicroRNAs ( miRNAs ) non-coding small RNAs participate regulating activity osteoblasts osteoclast postranslationally target certain gene expression . miR-133 -135 target BMP-2 , Runx2 , Smad5 regulate osteoblast differentiation . Likewise , miR-141 -200a negatively regulate osteoblast differentiation . Nevertheless , functional role miRNAs osteoporosis men still unknown . In addition , miRNA stable detect blood novel biomarkers certain disease . A recent study analyze level miRNAs circulate monocyte 10 high 10 low bone mineral density postmenopausal Caucasian woman find miR-133a potential biomarker postmenopausal osteoporosis . In comparison , roles blood miRNAs osteoporosis men evaluate . Therefore , study aim evaluate role specific miRNAs osteoporosis men .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>1 . Twenty oriental men ( mean age , 80 year ; age range , 7090 year ) . 2 . Candidates clinical evidence history focal lesion femur ; previous hip surgery irradiation ; hip trauma ; spinal trauma . 3 . Participants thoroughly understood sign consent form . 4 . Ten normal adult male ( age range , 2040 year ) . 1 . Participants secondary cause osteoporosis , thyroid , parathyroid disease , osteogenesis imperfect osteomalacia . 2 . Participants Paget 's disease , serious liver disease , serious renal disease ( indicated serum creatinine concentration 1.6mg/dL ) . 3 . Participants currently history use steroid hormone replacement therapy . 4 . Participants fail sign consent form .</criteria>
	<gender>Male</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>male osteoporosis</keyword>
	<keyword>miRNA</keyword>
	<keyword>biomarker</keyword>
</DOC>